NCT06637423
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06637423
Title A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027) (TroFuse-027)
Acronym TroFuse-027
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | GBR | FRA | ESP | CAN

Facility Status City State Zip Country Details
Michael G Oefelein Clinical Trials ( Site 0053) RECRUITING Bakersfield California 93301 United States Details
Moffitt Cancer Center ( Site 0057) RECRUITING Tampa Florida 33612 United States Details
Northwestern University ( Site 0051) RECRUITING Chicago Illinois 60611 United States Details
Johns Hopkins University ( Site 0055) RECRUITING Baltimore Maryland 21287 United States Details
Princess Margaret Cancer Centre ( Site 0003) RECRUITING Toronto Ontario M5G 2M9 Canada Details
CIUSSS de l'Estrie-CHUS ( Site 0002) RECRUITING Sherbrooke Quebec J1H 5N4 Canada Details
Hôpital Claude Huriez ( Site 0012) RECRUITING Lille Nord 59037 France Details
HENRI MONDOR HOSPITAL ( Site 0011) RECRUITING Créteil Val-de-Marne 94010 France Details
Gustave Roussy ( Site 0013) RECRUITING Villejuif Val-de-Marne 94805 France Details
Erasmus Medisch Centrum ( Site 0032) RECRUITING Rotterdam South Holland 3015 GD Netherlands Details
Hospital Universitario Virgen de la Victoria ( Site 0043) RECRUITING Málaga Andalusia 29010 Spain Details
Hospital Universitario 12 de Octubre ( Site 0042) RECRUITING Madrid 28041 Spain Details
St Bartholomew s Hospital ( Site 0061) RECRUITING London London, City of EC1A 7BE United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field